Browsing Tag
gemcitabine
7 posts
How the TIGeR-PaC sub-study could influence future thinking around chemotherapy tolerability and precision delivery
RenovoRx’s TIGeR-PaC sub-study highlights how targeted chemotherapy delivery could reshape pancreatic cancer treatment strategy. Read more.
May 28, 2026
Could repeated VCN-01 dosing overcome long-standing survival barriers in metastatic PDAC?
Theriva Biologics advances VCN-01 into phase 3 for metastatic pancreatic cancer with FDA and EMA guidance. Discover what this means for trial execution and survival outcomes.
March 26, 2026
Amplia Therapeutics (ASX:ATX) reports five complete responses and improved survival in ACCENT pancreatic cancer trial
Amplia Therapeutics (ASX:ATX) posts 7.8% complete response rate and 11.1-month mOS in ACCENT pancreatic cancer trial. Read the full strategic analysis.
March 23, 2026
Johnson & Johnson fortifies urologic oncology pipeline with compelling Inlexzo results
Johnson & Johnson's new data show Inlexzo delivers strong one-year disease-free survival. Find out how it could shift bladder cancer care.
December 6, 2025
Relmada gains FDA support for dual Phase 3 study paths of NDV-01 in non-muscle invasive bladder cancer
Find out how Relmada secured FDA alignment on dual Phase 3 paths for NDV-01 in NMIBC, opening two routes toward approval and a potential new bladder-sparing therapy.
November 4, 2025
Understanding pancreatic cancer: causes, symptoms, tests, and treatments explained
Learn everything about pancreatic cancer in this comprehensive guide—what causes it, how it develops, signs to watch for, diagnostic methods, and current treatment options.
July 12, 2025
Zentalis Pharmaceuticals reports promising results from Phase 1 trial of azenosertib, gemcitabine combo
Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a trailblazer in developing small molecule therapeutics for cancer, has released the final…
May 25, 2024